Chemical inactivation of recombinant vaccinia viruses and the effects on antigenicity and immunogenicity of recombinant simian immunodeficiency virus envelope glycoproteins

被引:9
作者
Hulskotte, EGJ
Dings, MEM
Norley, SG
Osterhaus, ADME
机构
[1] ERASMUS UNIV ROTTERDAM,INST VIROL,NL-3000 DR ROTTERDAM,NETHERLANDS
[2] NATL INST PUBL HLTH & ENVIRONM PROTECT,LAB VACCINE DEV & IMMUNE MECHANISMS,NL-3720 BA BILTHOVEN,NETHERLANDS
[3] PAUL EHRLICH INST,D-6070 LANGEN,GERMANY
关键词
paraformaldehyde; vaccinia virus; SIV;
D O I
10.1016/S0264-410X(97)00131-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The efficiency of paraformaldehyde (PFA) and binary ethylenimine (BEI) in inactivating recombinant vaccinia virus (rVV), present in baby hamster-kidney cells expressing simian immunodeficiency virus envelope glycoproteins (SIV-Env), was measured in a series of inactivation studies. Both compounds were shown to be effective in reducing rVV titres, The use of standard 3-day titration assays proved to be inadequate to measure PFA inactivation since upon prolonged incubation residual rVV infectivity was detected in cultures negative at 3 days. Different procedures using PFA or BEI were selected to assess their influence on the antigenicity and immunogenicity of rVV expressed SIV-Env, Antigenicity, as defined by the ability to react with a panel of monoclonal antibodies recognizing major antigenic sites, and immunogenicity, as defined by the ability to induce SIV envelope specific and virus neutralizing serum antibodies in rats, proved to be preserved after either inactivation procedure, These data show that both protocols using PFA or-BEI can be used successfully as part of the procedures to remove residual rVV infectivity. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:1839 / 1845
页数:7
相关论文
共 29 条
[1]  
BABCOCK GF, 1994, METHOD CELL BIOL, V41, P81
[2]   INACTIVATION OF VIRAL-ANTIGENS FOR VACCINE PREPARATION WITH PARTICULAR REFERENCE TO THE APPLICATION OF BINARY ETHYLENIMINE [J].
BAHNEMANN, HG .
VACCINE, 1990, 8 (04) :299-303
[3]  
BOTTIGER M, 1958, Arch Gesamte Virusforsch, V8, P259, DOI 10.1007/BF01241487
[4]  
BROWN F, 1993, DEV BIOL STAND, V81, P103
[5]  
DARLING AJ, 1993, DEV BIOL STAND, V81, P221
[6]   PROTECTION OF RHESUS MACAQUES FROM SIV INFECTION BY IMMUNIZATION WITH DIFFERENT EXPERIMENTAL SIV VACCINES [J].
DEVRIES, P ;
HEENEY, JL ;
BOES, J ;
DINGS, MEM ;
HULSKOTTE, EGJ ;
DUBBES, R ;
KOORNSTRA, W ;
TENHAAFT, P ;
AKERBLOM, L ;
ERIKSSON, S ;
MOREIN, B ;
NORLEY, S ;
OSTERHAUS, ADME .
VACCINE, 1994, 12 (15) :1443-1452
[7]  
DOYLE CB, 1995, J VIROL, V69, P1257
[8]   ANTIGENIC STRUCTURE OF POLIOVIRUS IN INACTIVATED VACCINES [J].
FERGUSON, M ;
WOOD, DJ ;
MINOR, PD .
JOURNAL OF GENERAL VIROLOGY, 1993, 74 :685-690
[9]  
GARD S, 1957, Arch Gesamte Virusforsch, V7, P471, DOI 10.1007/BF01241963
[10]  
GERETTI AM, IN PRESS VACCINE